COURTNEE HOEBELHEINRICH: Open Payments
NPI 1578872206 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 20 payments from 9 companies in 2025. Trend: 2023 $435 · 2024 $205 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $103 |
| Biogen, Inc. | 3 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Hologic Sales and Service, LLC | 2 | $72 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $42 |
| SHIELD THERAPEUTICS INC | 1 | $41 |
| Exeltis, USA Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Organon LLC | 1 | $6 |
Products named: Veozah, ZURZUVAE, MYOSURE TISSUE REMOVAL DEVICE, MYFEMBREE, ACCRUFER, GEMTESA, SLYND, Wegovy.
Industry payments across TX — which companies pay providers there.
